Richard Chin
CIK 1337252 · Chief Executive Officer · last filed 2026-05-20
Richard Chin is a Chief Executive Officer who has filed 58 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for CTKB, was dated May 20, 2026. Across all open-market trades the lifetime net is −$7.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $88.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$88.7K
6
58
-$7.11M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CTKB | Director | 22,392 | $3.96 | $88.7K | $0 | 5 | 2026-05-20 |
| Kindred Biosciences, Inc. (KIN) Delisted | Chief Executive Officer | 0 | $9.25 | $0 | -$5.88M | 32 | 2021-08-30 |
| SELLAS Life Sciences Group, Inc. (GALE) Delisted | Director | 31,339 | — | — | -$1.23M | 11 | 2017-10-10 |
| ImmunoCellular Therapeutics, Ltd. (IMUC) Delisted | Director | — | — | — | $0 | 2 | 2013-09-24 |
| SELLAS Life Sciences Group, Inc. (RXII) Delisted | Director | — | — | — | $0 | 6 | 2011-09-29 |
| Oncotelic Therapeutics, Inc. (OXGN) Delisted | President and CEO | 392,074 | — | — | $0 | 2 | 2008-01-15 |
Recent Filings
58 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-20 | CTKB | Exer (M) | +6,107 | $0 | EDGAR |
| 2026-03-12 | CTKB | Exer (M) | +6,107 | $0 | EDGAR |
| 2025-11-20 | CTKB | Exer (M) | +6,107 | $0 | EDGAR |
| 2025-08-20 | CTKB | Exer (M) | +4,071 | $0 | EDGAR |
| 2025-06-20 | CTKB | Grant (A) | — | $0 | EDGAR |
| 2021-08-30 | Kindred Biosciences, Inc. (KIN) Delisted | Disp (D) | −1,713,271 | -$15.85M | EDGAR |
| 2021-08-04 | Kindred Biosciences, Inc. (KIN) Delisted | Mixed | −360,000 | -$368.2K | EDGAR |
| 2021-07-07 | Kindred Biosciences, Inc. (KIN) Delisted | Sell (S) | −40,000 | -$367.1K | EDGAR |
| 2021-06-17 | Kindred Biosciences, Inc. (KIN) Delisted | Sell (S) | −40,000 | -$367.3K | EDGAR |
| 2021-02-03 | Kindred Biosciences, Inc. (KIN) Delisted | Mixed | +5,918 | -$32.9K | EDGAR |